By Denny JacobThe Food and Drug Administration on Friday said there shouldn't be an immediate significant impact on the supply of drugs producted at a Pfizer manufacturing facility in North Carolina that suffered extensive damage from a tornado earlier this week. The drugs produced at the facility are currently available at hospitals or are in the distribution system. It noted that while Pfizer has one-third of the total sterile injectable drug market for hospitals in the U.S., the affected facility only makes 25% of Pfizer's supply of the product. The FDA said its initial analysis has identified less than 10 drugs that the plant is the sole source of for the U.S. market. Pfizer earlier Friday said most of this week's tornado damage to its Rocky Mount, N.C. manufacturing plant affected its warehouse facility that stores raw materials for drugs, packaging materials and manufactured medicines awaiting shipment.

Source: Wall Street Journal July 22, 2023 12:20 UTC